Target intelligence / Profile preview

Elongation factor Tu (EF-Tu) (EF-Tu)

Target
EF-Tu
Molecular classification
Enzyme, GTPase, Translation factor
01

Overview

Elongation factor Tu (EF-Tu) is a highly conserved and essential bacterial GTPase that plays a central role in protein biosynthesis [UniProt: Q18C08]. It is responsible for transporting aminoacyl-tRNA to the A-site of the ribosome in a GTP-dependent manner. Upon correct codon-anticodon recognition, GTP is hydrolyzed to GDP, and the resulting EF-Tu•GDP complex is released from the ribosome to be recycled by the guanine nucleotide exchange factor EF-Ts. In Clostridioides difficile, EF-Tu has emerged as a significant therapeutic target, particularly for the development of narrow-spectrum antibiotics like LFF571 [PubMed: 23114770]. By inhibiting EF-Tu, these drugs halt bacterial translation, leading to cell death or growth inhibition. Because EF-Tu is distinct from its eukaryotic homolog (eEF-1A), it offers a high degree of selectivity for bacterial pathogens over human cells [Wikipedia: EF-Tu].

Other names
Bacterial elongation factor TutufGTP-binding protein EF-TuTranslation elongation factor TuEF-Tu•GDP complex
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to EF-Tu and preventing either the formation of the ternary complex with aminoacyl-tRNA or the release of EF-Tu from the ribosome after GTP hydrolysis [PubMed: 23114770].

03

Biological functions

Protein synthesisTranslation elongationGTP hydrolysistRNA transport
04

Disease associations

InfectionClostridioides difficile infection
05

Safety considerations

Antimicrobial resistanceDisruption of commensal gut microbiotaLimited spectrum of activity for specific analogs
06

Interacting drugs

Kirromycin

5 more in the full profile.

07

Biomarkers

Bacterial loadC. difficile toxin A/BEF-Tu protein levels

Beyond the preview

Go deeper on Elongation factor Tu (EF-Tu) (EF-Tu).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elongation factor Tu (EF-Tu) (EF-Tu).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call